Focused on developing orally delivered biologic drugs, the company is a clinical-stage biotechnology firm working to replace injectable peptide and protein therapies with pill-based alternatives. Its pipeline centers on treatments for bone disorders and other conditions using a proprietary oral deli...
1 member of Congress has disclosed 1 trade in Entera Bio Ltd (ENTX), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-08-23 | MICHAEL T. MCCAUL | sell | $1K – $15K |